Denmark urges EU to tighten Russian visa restrictions after alleged assassination plot
Denmark has urged European Union countries to introduce tougher travel restrictions on Russian nationals following allegations that Moscow's in...
The United States has launched an investigation into Germany's pharmaceutical pricing policies to determine whether they unfairly disadvantage American companies and restrict U.S. commerce.
U.S. Trade Representative Jamieson Greer said the probe would examine whether Germany's so-called “persistent underpayment” for innovative medicines is unreasonable or discriminatory.
The investigation, launched under Section 301 of the Trade Act of 1974, follows months of discussions between Washington and Berlin, according to Greer.
Greer said President Donald Trump believes American patients should not shoulder a disproportionate share of global pharmaceutical research and development costs.
He also criticized reports that Germany is considering measures that could further reduce spending on innovative medicines, calling it a "serious step backwards."
Germany is pursuing healthcare reforms aimed at lowering insurance costs and saving more than €16 billion in healthcare spending.
The move comes amid longstanding criticism of high prescription drug prices in the United States. A 2024 RAND Corporation study found U.S. prescription drug prices were nearly three times higher than those in 33 other countries.
Supporters of Germany’s pricing system argue the policies are designed to keep medicines affordable and control healthcare spending, while Washington says trading partners should contribute more to funding pharmaceutical innovation.
European leaders backing Ukraine met in Berlin on Thursday 19 November and warned that no peace deal should be settled without them.
Three people have been killed and around 15 injured after Russian ballistic missiles struck three bridges over the Dnipro River in Kyiv, according to the Ukrainian capital’s mayor, Vitali Klitschko.
Azerbaijani President Ilham Aliyev met Vietnamese Prime Minister Le Minh Hung in Hanoi on 20 November, during a visit highlighting the longstanding friendship and growing strategic partnership between the two countries.
Britain and the European Union have reached an agreement to ease trade, expand opportunities for young people and deepen economic ties, in a major step towards rebuilding relations after Brexit.
Georgia has declared 22 November 2026 a national day of mourning following a deadly residential building collapse in the Kvemo Ponichala district of Tbilisi.
For the first time in more than a quarter of a century, the United States can no longer say it has eliminated measles as health experts warn the American outbreak reflects a collapse in trust in vaccines.
A new study in mice suggests the brain’s protective barrier does more than block harmful substances. It also delivers essential proteins from the body, a process that may break down early in Alzheimer’s disease and offer a new target for treatment.
Here's your AnewZ Daily Brief for the 5th of November, as health emergencies, humanitarian crises, political shifts, and cybersecurity threats put governments and essential services under pressure across the globe. Here are five stories worth your attention.
Kazakhstan plans to manufacture 494 types of medicines through eight major investment projects worth a combined $862 million, Health Minister Akmaral Alnazarova announced on 3 November, local media reported.
Dengue fever has killed more people in Bangladesh this year than in the whole of 2025, with October the deadliest month so far, data from Bangladesh's Health Ministry shows.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment